LPTX
Price
$0.30
Change
+$0.04 (+15.38%)
Updated
Jun 30, 02:14 PM (EDT)
Capitalization
11.44M
TECX
Price
$19.81
Change
+$0.01 (+0.05%)
Updated
Jun 30, 02:22 PM (EDT)
Capitalization
369.72M
Interact to see
Advertisement

LPTX vs TECX

Header iconLPTX vs TECX Comparison
Open Charts LPTX vs TECXBanner chart's image
Leap Therapeutics
Price$0.30
Change+$0.04 (+15.38%)
Volume$36.25K
Capitalization11.44M
Tectonic Therapeutic
Price$19.81
Change+$0.01 (+0.05%)
Volume$117
Capitalization369.72M
LPTX vs TECX Comparison Chart in %
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. TECX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a Buy and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LPTX: $0.26 vs. TECX: $19.80)
Brand notoriety: LPTX and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 64% vs. TECX: 779%
Market capitalization -- LPTX: $11.44M vs. TECX: $369.72M
LPTX [@Biotechnology] is valued at $11.44M. TECX’s [@Biotechnology] market capitalization is $369.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, TECX is a better buy in the long-term than LPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 5 TA indicator(s) are bullish while TECX’s TA Score has 3 bullish TA indicator(s).

  • LPTX’s TA Score: 5 bullish, 5 bearish.
  • TECX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LPTX is a better buy in the short-term than TECX.

Price Growth

LPTX (@Biotechnology) experienced а -31.85% price change this week, while TECX (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

LPTX is expected to report earnings on May 13, 2025.

TECX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($370M) has a higher market cap than LPTX($11.4M). TECX YTD gains are higher at: -57.115 vs. LPTX (-90.901). TECX has higher annual earnings (EBITDA): -56.94M vs. LPTX (-71.67M). TECX has more cash in the bank: 306M vs. LPTX (32.7M). LPTX has less debt than TECX: LPTX (154K) vs TECX (2.63M). LPTX (0) and TECX (0) have equivalent revenues.
LPTXTECXLPTX / TECX
Capitalization11.4M370M3%
EBITDA-71.67M-56.94M126%
Gain YTD-90.901-57.115159%
P/E RatioN/AN/A-
Revenue00-
Total Cash32.7M306M11%
Total Debt154K2.63M6%
FUNDAMENTALS RATINGS
LPTX vs TECX: Fundamental Ratings
LPTX
TECX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9993
PRICE GROWTH RATING
1..100
9663
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (21) in the null industry is in the same range as LPTX (38) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as LPTX (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's SMR Rating (93) in the null industry is in the same range as LPTX (99) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's Price Growth Rating (63) in the null industry is somewhat better than the same rating for LPTX (96) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than LPTX’s over the last 12 months.

TECX's P/E Growth Rating (100) in the null industry is in the same range as LPTX (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPTXTECX
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFEIX56.200.55
+0.99%
Janus Henderson European Focus I
BLYRX35.330.28
+0.80%
American Beacon Man Lg Cp Growth R6
JSGAX28.550.21
+0.74%
JHancock U.S. Growth A
ARSKX71.270.50
+0.71%
Archer Stock
JATSX64.350.41
+0.64%
Janus Henderson Glb Tech and Innovt S

LPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-6.47%
SABS - LPTX
47%
Loosely correlated
-5.06%
INKT - LPTX
42%
Loosely correlated
-6.31%
AXON - LPTX
40%
Loosely correlated
+1.86%
TECX - LPTX
39%
Loosely correlated
-1.32%
AMRN - LPTX
35%
Loosely correlated
-1.19%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-1.32%
IGC - TECX
49%
Loosely correlated
-0.32%
LPTX - TECX
39%
Loosely correlated
-6.47%
ATHE - TECX
37%
Loosely correlated
+0.34%
IMNM - TECX
36%
Loosely correlated
-0.23%
SRPT - TECX
35%
Loosely correlated
-0.70%
More